Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Fröhlich

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Dermatology and Therapy|May 9, 2020
Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic DirectionsDennis Niebel, Judith Sirokay, Friederike Hoffmann, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2020
Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB-IV M1c melanoma patientsAnne Fröhlich, Dennis Niebel, Simon Fietz, et al.
The Journal of Dermatology|February 26, 2020
Treatment of metastasized melanoma with combined checkpoint inhibition in a patient with highly active multiple sclerosisFriederike Hoffmann, Anne Fröhlich, Niklas Schäfer, et al.
The American Naturalist|March 31, 2016
Sex-Specific Arrival Times on the Breeding Grounds: Hybridizing Migratory Skuas Provide Empirical Support for the Role of Sex RatiosSimeon Lisovski, Anne Fröhlich, Matthew von Tersch, et al.
Frontiers in Immunology|December 25, 2023
Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case reportSimon Fietz, Anne Fröhlich, Cornelia Mauch, et al.
Frontiers in Oncology|May 28, 2020
Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case ReportAnne Fröhlich, Friederike Hoffmann, Dennis Niebel, et al.
Dermatology and Therapy|February 23, 2021
Grzybowski's Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease-An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case ReportRegina Havenith, Luka de Vos, Anne Fröhlich, et al.
Melanoma Research|February 3, 2023
DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanomaFriederike Hoffmann, Anne Fröhlich, Judith Sirokay, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 14, 2021
Telephone follow-up for monitoring of complications and boosting patient satisfaction after inpatient dermatosurgery: a prospective two-center studyChristoph Löser, Anne Fröhlich, Sietske Poortinga, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 18, 2022
Christoph Löser, Anne Fröhlich, Sietske Poortinga, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Dermatology and Therapy|May 9, 2020
Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic DirectionsDennis Niebel, Judith Sirokay, Friederike Hoffmann, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2020
Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB-IV M1c melanoma patientsAnne Fröhlich, Dennis Niebel, Simon Fietz, et al.
The Journal of Dermatology|February 26, 2020
Treatment of metastasized melanoma with combined checkpoint inhibition in a patient with highly active multiple sclerosisFriederike Hoffmann, Anne Fröhlich, Niklas Schäfer, et al.
The American Naturalist|March 31, 2016
Sex-Specific Arrival Times on the Breeding Grounds: Hybridizing Migratory Skuas Provide Empirical Support for the Role of Sex RatiosSimeon Lisovski, Anne Fröhlich, Matthew von Tersch, et al.
Frontiers in Immunology|December 25, 2023
Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case reportSimon Fietz, Anne Fröhlich, Cornelia Mauch, et al.
Frontiers in Oncology|May 28, 2020
Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case ReportAnne Fröhlich, Friederike Hoffmann, Dennis Niebel, et al.
Dermatology and Therapy|February 23, 2021
Grzybowski's Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease-An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case ReportRegina Havenith, Luka de Vos, Anne Fröhlich, et al.
Melanoma Research|February 3, 2023
DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanomaFriederike Hoffmann, Anne Fröhlich, Judith Sirokay, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 14, 2021
Telephone follow-up for monitoring of complications and boosting patient satisfaction after inpatient dermatosurgery: a prospective two-center studyChristoph Löser, Anne Fröhlich, Sietske Poortinga, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 18, 2022
Christoph Löser, Anne Fröhlich, Sietske Poortinga, et al.
Pageof 2